CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 209 filers reported holding CONMED CORP in Q3 2018. The put-call ratio across all filers is 2.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $400,274 | -25.8% | 3,969 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $539,347 | +40.7% | 3,969 | +7.6% | 0.00% | 0.0% |
| Q1 2023 | $383,243 | +1.2% | 3,690 | -13.6% | 0.00% | 0.0% |
| Q4 2022 | $378,760 | +34.8% | 4,273 | +21.9% | 0.00% | +100.0% |
| Q3 2022 | $281,000 | -15.4% | 3,505 | +1.0% | 0.00% | -50.0% |
| Q2 2022 | $332,000 | -4.0% | 3,469 | +48.9% | 0.00% | +100.0% |
| Q1 2022 | $346,000 | +2.7% | 2,330 | -1.9% | 0.00% | 0.0% |
| Q4 2021 | $337,000 | -4.0% | 2,376 | -11.5% | 0.00% | -50.0% |
| Q3 2021 | $351,000 | -5.1% | 2,686 | -0.3% | 0.00% | 0.0% |
| Q2 2021 | $370,000 | -47.4% | 2,695 | -49.9% | 0.00% | 0.0% |
| Q1 2021 | $704,000 | +124.2% | 5,384 | +91.8% | 0.00% | 0.0% |
| Q4 2020 | $314,000 | +38.9% | 2,807 | -2.2% | 0.00% | +100.0% |
| Q3 2020 | $226,000 | +10.2% | 2,870 | +0.6% | 0.00% | 0.0% |
| Q2 2020 | $205,000 | -33.0% | 2,853 | +4.2% | 0.00% | -50.0% |
| Q4 2019 | $306,000 | +17.2% | 2,737 | +0.8% | 0.00% | +100.0% |
| Q3 2019 | $261,000 | -13.3% | 2,714 | -28.5% | 0.00% | -50.0% |
| Q3 2018 | $301,000 | -66.5% | 3,794 | -69.1% | 0.00% | -60.0% |
| Q2 2018 | $898,000 | -43.4% | 12,269 | -51.0% | 0.01% | -44.4% |
| Q1 2018 | $1,586,000 | -23.7% | 25,044 | -38.6% | 0.01% | -25.0% |
| Q4 2017 | $2,079,000 | -1.7% | 40,794 | +1.2% | 0.01% | -7.7% |
| Q3 2017 | $2,114,000 | -0.5% | 40,294 | -3.4% | 0.01% | 0.0% |
| Q2 2017 | $2,124,000 | +5.1% | 41,694 | -8.4% | 0.01% | +8.3% |
| Q1 2017 | $2,020,000 | -10.7% | 45,494 | -11.1% | 0.01% | -14.3% |
| Q4 2016 | $2,261,000 | +16.1% | 51,191 | +5.4% | 0.01% | +16.7% |
| Q3 2016 | $1,947,000 | +40.2% | 48,591 | +67.0% | 0.01% | +33.3% |
| Q2 2016 | $1,389,000 | +60.4% | 29,091 | +45.9% | 0.01% | +28.6% |
| Q1 2014 | $866,000 | -61.2% | 19,938 | -62.1% | 0.01% | -53.3% |
| Q4 2013 | $2,233,000 | +25.2% | 52,542 | +0.1% | 0.02% | +25.0% |
| Q3 2013 | $1,783,000 | -92.6% | 52,499 | -93.2% | 0.01% | -86.5% |
| Q2 2013 | $24,237,000 | -2.6% | 775,825 | +6.2% | 0.09% | -3.3% |
| Q1 2013 | $24,886,000 | +47.7% | 730,650 | +21.2% | 0.09% | +37.3% |
| Q4 2012 | $16,853,000 | – | 602,975 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |